PTPN2 deletion in T cells promotes anti-tumour immunity and CAR T cell efficacy in solid tumours
Florian Wiede(Peter MacCallum Cancer Centre), Tony Tiganis(Discovery Institute)
Cited by 2
Related Papers
PTPN2 phosphatase deletion in T cells promotes anti‐tumour immunity and CAR T‐cell efficacy in solid tumours
|The EMBO Journal|2019|136
A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity
|Nature Communications|2023|81
PTPN2 attenuates T-cell lymphopenia-induced proliferation
|Nature Communications|2014|66